DEPARTMENT OF STATE

Division of Professional Regulation

Board of Pharmacy

GENERAL NOTICE

NOTICE

2500 Board of Pharmacy

Pursuant to 24 Del.C. §2506(a)(1), the Delaware Board of Pharmacy (“Board”) has proposed revisions to its regulation.

The Board proposed to amend subsection 5.1.6, pertaining to compounding; a new Section 21.0 was added concerning work conditions for pharmacists; and a new Section 22.0 was added to set forth the parameters where a pharmacist may decline to fill a prescription based on professional judgment.

The proposed amendments were published on page 507 of the January 1, 2025 Delaware Register of Register of Regulations, Volume 28, Issue 7. The public hearing was scheduled for February 19, 2025 at 9:30 a.m. However, the hearing was cancelled. As a result, the Board will now hold a public hearing on April 16, 2025 at 9:30 a.m. in the second floor conference room A of the Cannon Building, 861 Silver Lake Boulevard, Dover, Delaware. Anyone wishing to receive a copy of the proposed regulation may obtain a copy from the Delaware Board of Pharmacy, 861 Silver Lake Boulevard, Dover, Delaware 19904. Persons wishing to submit written comments may forward these to the Board at the above address or at ruthm.dixon@delaware.gov.

In accordance with 29 Del.C. §10118(a), the final date to receive written comments will be May 1, 2025. The Board will deliberate on all of the public comments at its next regularly scheduled meeting.